Manuel Vázquez‐Carrera

11.3k total citations · 2 hit papers
191 papers, 9.2k citations indexed

About

Manuel Vázquez‐Carrera is a scholar working on Molecular Biology, Physiology and Epidemiology. According to data from OpenAlex, Manuel Vázquez‐Carrera has authored 191 papers receiving a total of 9.2k indexed citations (citations by other indexed papers that have themselves been cited), including 116 papers in Molecular Biology, 77 papers in Physiology and 48 papers in Epidemiology. Recurrent topics in Manuel Vázquez‐Carrera's work include Peroxisome Proliferator-Activated Receptors (82 papers), Adipose Tissue and Metabolism (62 papers) and Metabolism, Diabetes, and Cancer (33 papers). Manuel Vázquez‐Carrera is often cited by papers focused on Peroxisome Proliferator-Activated Receptors (82 papers), Adipose Tissue and Metabolism (62 papers) and Metabolism, Diabetes, and Cancer (33 papers). Manuel Vázquez‐Carrera collaborates with scholars based in Spain, Switzerland and United States. Manuel Vázquez‐Carrera's co-authors include Xavier Palomer, Juan C. Laguna, Emma Barroso, Walter Wahli, Rosa María Galán Sánchez, Marta Alegret, Ricardo Rodríguez‐Calvo, Javier Pizarro‐Delgado, H. J. Keller and Frank J. Gonzalez and has published in prestigious journals such as Nature, Journal of the American Chemical Society and Journal of Biological Chemistry.

In The Last Decade

Manuel Vázquez‐Carrera

188 papers receiving 9.1k citations

Hit Papers

The PPARα–leukotriene B4 pathway to inflammation control 1996 2026 2006 2016 1996 2017 250 500 750 1000

Peers

Manuel Vázquez‐Carrera
Peter J. Voshol Netherlands
Michael J. Jurczak United States
João Paulo Camporez United States
Yasuo Ido United States
Steven M. Watkins United States
Joel P. Berger United States
Peter J. Voshol Netherlands
Manuel Vázquez‐Carrera
Citations per year, relative to Manuel Vázquez‐Carrera Manuel Vázquez‐Carrera (= 1×) peers Peter J. Voshol

Countries citing papers authored by Manuel Vázquez‐Carrera

Since Specialization
Citations

This map shows the geographic impact of Manuel Vázquez‐Carrera's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Manuel Vázquez‐Carrera with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Manuel Vázquez‐Carrera more than expected).

Fields of papers citing papers by Manuel Vázquez‐Carrera

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Manuel Vázquez‐Carrera. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Manuel Vázquez‐Carrera. The network helps show where Manuel Vázquez‐Carrera may publish in the future.

Co-authorship network of co-authors of Manuel Vázquez‐Carrera

This figure shows the co-authorship network connecting the top 25 collaborators of Manuel Vázquez‐Carrera. A scholar is included among the top collaborators of Manuel Vázquez‐Carrera based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Manuel Vázquez‐Carrera. Manuel Vázquez‐Carrera is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Palomer, Xavier, et al.. (2025). Targeting AMPK as a potential treatment for hepatic fibrosis in MASLD. Trends in Pharmacological Sciences. 46(6). 551–566. 6 indexed citations
3.
Olloquequi, Jordi, Amanda Cano, Ana Fortuna, et al.. (2025). Licochalcone A prevents cognitive decline in a lipopolysaccharide-induced neuroinflammation mice model. Molecular Medicine. 31(1). 54–54. 3 indexed citations
4.
Antelo-Riveiro, Paula, et al.. (2024). Rapid diagnosis and severity scale of post-COVID condition using advanced spectroscopy. Spectrochimica Acta Part A Molecular and Biomolecular Spectroscopy. 328. 125474–125474.
5.
Pormohammad, Ali, Lieve Naesens, Santiago Vázquez, et al.. (2024). Novel pentafluorosulfanyl-containing triclocarban analogs selectively kill Gram-positive bacteria. Microbiology Spectrum. 12(6). e0007124–e0007124. 4 indexed citations
6.
Barroso, Emma, Ricardo Rodríguez‐Calvo, Antoni Camins, et al.. (2024). PPARβ/δ upregulates the insulin receptor β subunit in skeletal muscle by reducing lysosomal activity and EphB4 levels. Cell Communication and Signaling. 22(1). 595–595. 1 indexed citations
7.
Palomer, Xavier, Jesús M. Salvador, Christian Griñán‐Ferré, et al.. (2024). GADD45A: With or without you. Medicinal Research Reviews. 44(4). 1375–1403. 31 indexed citations
8.
Barroso, Emma, M. Bernard, Patricia Rada, et al.. (2024). GDF15 activates AMPK and inhibits gluconeogenesis and fibrosis in the liver by attenuating the TGF-β1/SMAD3 pathway. Metabolism. 152. 155772–155772. 20 indexed citations
9.
Griñán‐Ferré, Christian, Aina Bellver‐Sanchís, Emma Barroso, et al.. (2024). Deletion of Gadd45a Expression in Mice Leads to Cognitive and Synaptic Impairment Associated with Alzheimer’s Disease Hallmarks. International Journal of Molecular Sciences. 25(5). 2595–2595. 5 indexed citations
10.
Matěj, Adam, Ana Sánchez‐Grande, Manuel Vázquez‐Carrera, et al.. (2024). On-Surface Synthesis of a Radical 2D Supramolecular Organic Framework. Journal of the American Chemical Society. 146(5). 3531–3538. 15 indexed citations
11.
Barroso, Emma, Andreea L. Turcu, Patricia Rada, et al.. (2023). Soluble epoxide hydrolase-targeting PROTAC activates AMPK and inhibits endoplasmic reticulum stress. Biomedicine & Pharmacotherapy. 168. 115667–115667. 4 indexed citations
12.
Tan, Min, Santiago Vázquez, Jingwen Zhang, et al.. (2023). Abstract 638: EPB-53 prevents NASH-HCC transition via regulation of SPHK1-S1P-HIPPO signaling and immune modulation in a murine model. Cancer Research. 83(7_Supplement). 638–638. 1 indexed citations
13.
Aguilar-Recarte, David, Emma Barroso, Xavier Palomer, Walter Wahli, & Manuel Vázquez‐Carrera. (2022). Knocking on GDF15’s door for the treatment of type 2 diabetes mellitus. Trends in Endocrinology and Metabolism. 33(11). 741–754. 29 indexed citations
14.
Calvó‐Tusell, Carla, Sílvia Osuna, Christophe Morisseau, et al.. (2021). From the Design to the In Vivo Evaluation of Benzohomoadamantane-Derived Soluble Epoxide Hydrolase Inhibitors for the Treatment of Acute Pancreatitis. Journal of Medicinal Chemistry. 64(9). 5429–5446. 19 indexed citations
15.
Cano, Amanda, Marta Espina, Miren Ettcheto, et al.. (2021). State of the Art on Toxicological Mechanisms of Metal and Metal Oxide Nanoparticles and Strategies to Reduce Toxicological Risks. Toxics. 9(8). 195–195. 30 indexed citations
16.
Pizarro‐Delgado, Javier, Ferran Feixas, Marı́a Isabel Loza, et al.. (2020). 2-Oxaadamant-1-yl Ureas as Soluble Epoxide Hydrolase Inhibitors: In Vivo Evaluation in a Murine Model of Acute Pancreatitis. Journal of Medicinal Chemistry. 63(17). 9237–9257. 19 indexed citations
17.
Botteri, Gaia, Helena Castillo‐Ecija, Guillem Pascual‐Pasto, et al.. (2018). Tissue Compatibility of SN‐38‐Loaded Anticancer Nanofiber Matrices. Advanced Healthcare Materials. 7(15). e1800255–e1800255. 5 indexed citations
18.
Rodríguez‐Calvo, Ricardo, Dipanjan Chanda, Yvonne Oligschlaeger, et al.. (2017). Small heterodimer partner (SHP) contributes to insulin resistance in cardiomyocytes. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids. 1862(5). 541–551. 9 indexed citations
19.
Vázquez‐Carrera, Manuel, Bharat Jasani, Jennifer B. Stott, et al.. (2009). Adenosine A2 receptor signalling mediates chromogranin A secretion from neuroendocrine Tumours. 19. 2 indexed citations
20.
Vázquez‐Carrera, Manuel, et al.. (2000). Receptores activados por proliferadores peroxisómicos (PPAR), metabolismo energético y aterosclerosis. Endocrinología y Nutrición. 47(10). 301–310. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026